Budpedia
Menu
All Articles
History & Education

Hawaii Urges Congress to Fully Deschedule Cannabis: What Total Federal Legalization Would Mean

Budpedia EditorialThursday, March 19, 20269 min read

Advertisement

Table of Contents

Hawaii Makes Bold Move: Pushing Congress Toward Complete Cannabis Descheduling

Hawaii just fired a significant shot across Congress's bow. In March 2026, the state legislature filed Senate Resolution 58 and Senate Concurrent Resolution 64—twin resolutions that ask the federal government to do something many thought impossible: completely remove cannabis from the Controlled Substances Act.

This isn't a quiet request. If passed, these resolutions will land on the desks of Congressional leadership, President Trump, and Hawaii's entire congressional delegation. Meanwhile, House Resolution HR130 echoes the same urgent message.

But here's the paradox: Hawaii doesn't even have legal recreational cannabis yet. A major recreational legalization bill stalled again during the 2026 legislative session. Yet state Senator Joy San Buenaventura (D) and state Senator Angus McKelvey (D)—the bill's sponsors—are calling for nothing less than federal descheduling.

What's driving this bold move? And more importantly, what would complete federal descheduling actually mean for the cannabis industry, banking, research, and ordinary Americans? Let's break it down.

The Descheduling vs. Rescheduling Distinction: Why It Matters

Before we dive deeper, let's clarify something crucial: descheduling and rescheduling are completely different things.

Rescheduling means moving cannabis from Schedule I [Quick Definition: The most restrictive federal drug classification, currently including heroin and cannabis] (currently its classification, alongside heroin and LSD) to a lower schedule—typically Schedule III [Quick Definition: A mid-level federal drug classification including ketamine and testosterone] with drugs like ketamine and anabolic steroids. This maintains federal control, allows some research, and potentially opens limited medical applications. President Trump signed an executive order pushing for rescheduling, though the Congressional Research Service recently removed language stating completion was "likely."

Descheduling means total removal from the Controlled Substances Act. No federal regulation. No Schedule I, II, III, or any other classification.

It's off the federal drug list entirely.

Hawaii's resolutions call for descheduling—the nuclear option for cannabis federalism.

What Hawaii Is Actually Asking Congress to Do

The resolutions passed by Hawaii's legislature contain three specific demands:

  1. Remove marijuana from the federal Controlled Substances Act completely. This is descheduling. Once removed, cannabis would fall under state jurisdiction entirely, with no federal criminal penalties for possession, distribution, or cultivation.

  2. Support state efforts to clear criminal records for prior marijuana convictions. This means clearing the slate for hundreds of thousands of Americans imprisoned or convicted under now-obsolete federal marijuana laws. It's criminal justice reform wrapped into cannabis policy.

  3. Allow marijuana businesses to access full banking services. Currently, cannabis companies operate in a cash-only nightmare because banks fear federal prosecution under money laundering statutes. Descheduling would unlock legitimate banking, lending, insurance, and financial services for a $47 billion industry expected in 2026.

If these resolutions pass both chambers, they're sent to Congressional leadership and the President as a formal statement of Hawaii's policy position. It's not binding, but it signals to Washington that even conservative-leaning states are ready for federal action.

The Banking Crisis: Why This Matters More Than You Think

Let's talk about the elephant in the room: banking.

Right now, 87% of Americans support cannabis legalization. Twenty-four states have legal adult-use markets. Yet the cannabis industry remains essentially unbanked—a $47 billion sector operating like a 1970s drug cartel, with cash stuffed into safes and armored trucks.

Why? The Controlled Substances Act and federal money laundering statutes create legal jeopardy for any bank that handles cannabis money, even in states where it's completely legal. This isn't paranoia.

Banks have faced actual federal prosecution and multi-million-dollar fines for servicing cannabis businesses.

The SAFE Banking Act [Quick Definition: Federal bill that would let banks serve cannabis businesses without fear of prosecution]—the Secure and Fair Enforcement Banking Act—has been Congress's half-measure response. It would provide banks with federal safe harbor to service cannabis businesses, but it maintains federal scheduling. Banks could legally work with cannabis companies, but the substance remains federally illegal.

Descheduling would be the full solution. Once cannabis is removed from the Controlled Substances Act, banks can serve the industry without any federal legal cloud. This means:

  • Legitimate lending for cultivation facilities and dispensaries
  • Business insurance and bonding
  • Tax services and accounting
  • Payment processing and credit cards
  • Investment capital flowing into the industry

This isn't just about convenience. Banking access is fundamental to industry legitimacy, safety, and taxation.

The Tax Nightmare: Section 280E

Here's something most people don't know about: Section 280E of the tax code.

This provision, originally designed to prevent drug dealers from deducting business expenses, makes it illegal for cannabis businesses to deduct ordinary business expenses like rent, utilities, employee salaries, and marketing. Only the cost of goods sold is deductible.

This creates a perverse incentive structure. A legal alcohol business deducts all operating expenses. A legal cannabis business—in states where it's completely legal—cannot.

The effective tax rate for cannabis businesses often exceeds 70% after accounting for state taxes, local taxes, and the Section 280E penalty.

Descheduling would fix this. Once cannabis is removed from the Controlled Substances Act, Section 280E no longer applies. Cannabis businesses would enjoy the same tax treatment as any other agricultural or retail business.

This would dramatically lower prices for consumers, increase profitability for operators, and boost tax revenue for states—a rare win-win-win.

Federal vs. State: The Research Blackout

Here's another hidden cost of federal scheduling: research is severely restricted.

Cannabis remains a Schedule I drug, which by definition means it has "no currently accepted medical use." This makes it extraordinarily difficult for researchers to study cannabis. The DEA controls all research, requiring special licenses, multiple approvals, and extensive paperwork just to run clinical trials.

Compare this to alcohol (completely legal and unscheduled) or even opioids (Schedule II [Quick Definition: High-restriction drug classification including oxycodone and fentanyl], allowing extensive research). Cannabis research in America lags behind Canada, Israel, and European countries where federal restrictions don't exist.

Descheduling would unleash cannabis research in American universities and medical centers. Scientists could study cannabinoid biology, potential therapeutic applications, safety profiles, and drug interactions without navigating a federal obstacle course.

Hawaii's Irony: A State Divided on Its Own Cannabis Policy

There's something striking about Hawaii's position here. The state is pushing Congress to deschedule cannabis while its own legislature remains gridlocked on recreational legalization.

In 2026, Hawaii's Senate approved a limited marijuana legalization bill—but the House punted on the reform, declining to move it forward. So Hawaii has a situation where state lawmakers are asking Congress to remove cannabis from federal law, but the state legislature can't reach consensus on its own legalization.

This suggests something important: Hawaii's descheduling push isn't primarily about in-state recreational access. It's about leadership on a national issue, supporting the broader movement toward federal reform, and positioning the state as a forward-thinking voice in cannabis policy.

State Senator Buenaventura and McKelvey are essentially saying: "We understand the future. The federal government needs to catch up."

The Broader Context: 24 States Have Already Decided

Hawaii's move comes amid a stunning shift in American cannabis policy.

Twenty-four states now have legal adult-use cannabis markets. Another 14 states have medical-only programs. Total adult-use market sales exceeded $40 billion in 2025 and are expected to reach $47 billion in 2026—making cannabis one of America's fastest-growing industries.

Public support has crystallized: 87% of Americans support legalization, according to recent polling. That includes majorities in both parties.

Yet federal law hasn't budged. Cannabis remains Schedule I. Federal banking restrictions persist.

Section 280E stays in place. Research restrictions endure.

The gap between state law and federal law has become absurd. A cannabis business can be completely legal in California, completely illegal in federal courts, unable to access banking, unable to deduct business expenses, and unable to be studied in federal research institutions.

Hawaii's resolutions attempt to close this gap—not through incremental rescheduling, but through complete descheduling.

Descheduling vs. Legalization: What's the Difference?

It's worth clarifying: descheduling ≠ automatic legalization.

If Congress deschedules cannabis, it doesn't create a federal right to grow, sell, or use cannabis. Instead, it removes federal prohibition. Individual states would then be free to legalize, decriminalize, or maintain prohibition as they choose.

Some states might continue banning cannabis entirely. Others would legalize recreational use. Some might stick with medical-only programs.

The point of descheduling isn't to impose uniformity—it's to remove the federal override.

This is actually what makes descheduling attractive to both progressives and federalists. Progressives see it as ending unjust federal prohibition. Federalists see it as restoring state sovereignty.

What Would Actually Change: A Practical Breakdown

If Hawaii's descheduling push succeeded and Congress removed cannabis from the Controlled Substances Act, here's what would change:

Immediately:

  • Banks could service cannabis businesses without federal legal risk
  • Researchers could study cannabis with standard institutional approval rather than DEA permission
  • Federal agents couldn't prosecute cannabis businesses operating legally under state law
  • The IRS couldn't apply Section 280E to cannabis businesses

Within months:

  • Existing state regulatory frameworks would continue undisturbed
  • Cannabis industry banking, lending, and insurance would normalize
  • Prices would likely drop as businesses enjoyed normal tax treatment
  • Research institutions would launch long-delayed studies

Within years:

  • States without legal cannabis would face pressure to establish regulated markets
  • Federal-state conflicts would resolve
  • Cannabis would be treated like alcohol: legal under state law, unscheduled federally

Would NOT automatically happen:

  • Federal legalization of recreational use (only state legalization)
  • Federal legalization of medical use (only state-level decisions)
  • Mandatory record expungement (though the resolutions urge Congress to support it)
  • Federal cannabis regulation or taxation

The Political Moment

Why is Hawaii making this push now, in 2026?

Part of it is momentum. With 24 states legalized and 87% public support, the inevitability of eventual reform feels palpable. State legislators see the writing on the wall.

Part of it is frustration. The SAFE Banking Act—which offers a half-measure compromise—has been stuck in Congress for years. Rescheduling promises remain unfulfilled.

Meanwhile, states have moved forward, and the federal-state conflict deepens.

And part of it is recognition: descheduling is actually the most federalist solution. It doesn't impose national legalization. It doesn't create federal cannabis regulation. It simply removes federal prohibition and lets states decide their own policy.

This makes descheduling appealable to a broad coalition—from progressive legalization advocates to states' rights conservatives.

The Path Forward

Hawaii's resolutions are unlikely to pass Congress this session. Cannabis descheduling remains controversial in Washington, even as it becomes normal across America.

But that's not the point. The point is that Hawaii's state legislature is on record—formally, in writing, sent to Congressional leadership—saying the federal government needs to deschedule cannabis. That's a significant political signal.

Each state that takes this position strengthens the case for federal reform. Resolutions accumulate. Public support hardens.

Business interests mobilize. Eventually, Congress responds.

We may not see full descheduling in 2026. But Hawaii's move confirms something: the direction is clear. The only question is timing.

Final Thoughts: The Disconnect Between State and Federal Reality

Hawaii's situation—pushing for federal descheduling while its own legislature remains divided on local legalization—perfectly captures the absurdity of current cannabis federalism.

Federal law says cannabis is Schedule I: dangerous, with no medical use, in the same category as heroin. Twenty-four states say cannabis is safer than alcohol. 87% of Americans agree. The cannabis industry generates $47 billion annually.

Yet the federal government maintains prohibition.

States are filling the void. They're setting policy, collecting taxes, regulating markets, and moving forward. The federal government sits on the sideline, increasingly irrelevant.

Hawaii's descheduling push isn't just about cannabis. It's about state sovereignty, federal flexibility, and the reality that American federalism works best when federal law sets a baseline that states can build upon—not when federal law contradicts state policy and market reality.

Descheduling would align federal law with reality. It would unlock banking, fix the tax code, unleash research, and restore state primacy over substance policy.

Is it inevitable? Maybe not. But with each state that joins Hawaii in calling for it, the likelihood grows.

And that's the real story here—not what Hawaii's resolutions will accomplish in Congress, but what they signal about America's shifting relationship with cannabis, federalism, and drug policy itself.


The Bottom Line: Hawaii's descheduling resolutions represent a fundamental shift in how states approach cannabis federalism—moving from asking for federal permission to declaring federal law obsolete and calling for its formal removal.


Pull-Quote Suggestions:

"Descheduling would unlock legitimate banking, lending, insurance, and financial services for a $47 billion industry expected in 2026."

"Yet the cannabis industry remains essentially unbanked—a $47 billion sector operating like a 1970s drug cartel, with cash stuffed into safes and armored trucks."

"The cannabis industry generates $47 billion annually."


Why It Matters: Hawaii lawmakers filed resolutions urging Congress to completely remove cannabis from the Controlled Substances Act. Here's what descheduling would change.

Tags:
Hawaii cannabis resolutiondeschedule cannabisfederal cannabis reformSAFE Banking Actcannabis descheduling

Advertisement